Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases

Abstract Background Pharmaceutical compounding of orphan active ingredients can offer cost-effective treatment to patients when no other drug product is available for a rare disease or during periods of drug product shortages. Additionally, it allows customized therapy for patients with rare disease...

Full description

Bibliographic Details

Published in:	Orphanet Journal of Rare Diseases
Main Authors:	V. Vanhoorne, E. Peeters, I. Van Tongelen, K. Boussery, E. Wynendaele, B. De Spiegeleer, J. P. Remon, C. Vervaet
Format:	Article
Language:	English
Published:	BMC 2019-08-01
Subjects:	Rare diseases Orphan active ingredients Pharmaceutical compounding
Online Access:	http://link.springer.com/article/10.1186/s13023-019-1154-x